Addex Therapeutics Ltd
ADXN8.380USD
+0.280+3.46%
收盤 08/04, 16:00（美東）報價延遲15分鐘
6.87M總市值
0.91本益比TTM
關於 Addex Therapeutics Ltd 公司
Addex Therapeutics Ltd 是一家位於瑞士的臨牀階段製藥公司。該公司專注於開發和商業化口服小分子藥物，這些藥物被稱爲神經系統疾病的變構調節劑。該公司的臨牀項目包括 dipraglurant (mGlu5 NAM)，這是帕金森病左旋多巴誘發的運動障礙 (PD-LID) 的 2a 期安慰劑對照臨牀試驗，並準備進入 PD-LID 的註冊試驗，以及 ADX71149 (mGlu2 正變構調節劑或 PAM)，這是由其合作伙伴 Janssen Pharmaceuticals, Inc 合作開發的，用於治療精神分裂症和焦慮性抑鬱症。它還在推進幾個臨牀前項目，包括用於治療疼痛、膀胱過度活動症和其他疾病的 GABABPAM、用於治療創傷後應激障礙的 mGlu7 NAM、用於治療輕度神經認知障礙的 mGlu2 NAM、用於治療帕金森病的 mGlu4 PAM 和用於治療神經退行性疾病的 mGlu3 PAM。
公司簡介
公司代碼ADXN
公司名稱Addex Therapeutics Ltd
上市日期May 22, 2007
CEOMr. Tim Dyer
員工數量2
證券類型Ordinary Share
年結日May 22
公司地址Chemin des Mines, 9
城市PLAN-LES-OUATES
上市交易所SIX Swiss Exchange
國家Switzerland
郵編1202
電話41228841555
網址https://www.addextherapeutics.com/en/
公司代碼ADXN
上市日期May 22, 2007
CEOMr. Tim Dyer
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Mikhail Kalinichev
Dr. Mikhail Kalinichev
Member of the Executive Management, Head of Translational Science
Member of the Executive Management, Head of Translational Science
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Lenaic Teyssedou
Mr. Lenaic Teyssedou
Member of the Executive Management, Head of Finance
Member of the Executive Management, Head of Finance
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
Dr. Isaac Manke
Dr. Isaac Manke
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Roger G. Mills
Dr. Roger G. Mills
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Mikhail Kalinichev
Dr. Mikhail Kalinichev
Member of the Executive Management, Head of Translational Science
Member of the Executive Management, Head of Translational Science
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Lenaic Teyssedou
Mr. Lenaic Teyssedou
Member of the Executive Management, Head of Finance
Member of the Executive Management, Head of Finance
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 2月23日 週日
更新時間: 2月23日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Citadel Advisors LLC
1.10%
GAMMA Investing LLC
0.01%
Other
98.89%
持股股東
持股股東
佔比
Citadel Advisors LLC
1.10%
GAMMA Investing LLC
0.01%
Other
98.89%
股東類型
持股股東
佔比
Hedge Fund
1.10%
Investment Advisor/Hedge Fund
0.01%
Other
98.89%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
12
12.04K
1.13%
-165.56K
2025Q1
16
13.11K
1.23%
-176.53K
2024Q4
17
15.10K
1.41%
-160.92K
2024Q3
22
37.43K
5.74%
-146.56K
2024Q2
21
38.45K
5.90%
-143.53K
2024Q1
20
36.44K
5.64%
-145.16K
2023Q4
19
195.87K
20.93%
+138.26K
2023Q3
18
73.39K
96.72%
+38.94K
2023Q2
18
50.23K
7.45%
-253.79K
2023Q1
17
333.00K
49.67%
+248.23K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Citadel Advisors LLC
11.74K
1.1%
-338.00
-2.80%
Mar 31, 2025
GAMMA Investing LLC
1.19K
0.11%
+182.00
+18.00%
Mar 31, 2025
Morgan Stanley & Co. LLC
100.00
0.01%
-1.80K
-94.74%
Mar 31, 2025
Rhumbline Advisers Ltd. Partnership
72.00
0.01%
-35.00
-32.71%
Mar 31, 2025
SBI Securities Co., Ltd.
5.00
0%
--
--
Mar 31, 2025
J. Stern & Co. LLP
--
0%
-107.83K
-100.00%
Mar 31, 2024
Armistice Capital LLC
--
0%
-43.00K
-100.00%
Mar 31, 2024
Baader Bank AG
--
0%
-960.00
-100.00%
Dec 31, 2023
Jane Street Capital, L.L.C.
--
0%
-529.00
-100.00%
Dec 31, 2023
New Enterprise Associates (NEA)
--
0%
-9.00K
-100.00%
Mar 31, 2024
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
公告日期
類型
比率
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
